We are live on ! Find out more
APRE icon

Aprea Therapeutics
APRE

39 hedge funds and large institutions have $591M invested in Aprea Therapeutics in 2019 Q4 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3.08% more ownership

Funds ownership: 0% → 3.08% (+3.1%)

Holders
39
Holders Change
+39
Holders Change %
–
% of All Funds
0.77%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
39
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$62.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$59M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$49.9M
4
SAM
Sectoral Asset Management
Quebec, Canada
+$40.5M
5
RSCM
Rock Springs Capital Management
Maryland
+$19.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
5VM
1
5AM Venture Management
California
$131M +$78.6M +142,633 New
RG
2
Redmile Group
California
$104M +$62.5M +113,436 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$98.3M +$59M +107,121 New
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$81M +$49.9M +90,543 New
SAM
5
Sectoral Asset Management
Quebec, Canada
$67.5M +$40.5M +73,517 New
RSCM
6
Rock Springs Capital Management
Maryland
$33.2M +$19.9M +36,200 New
BlackRock
7
BlackRock
New York
$15.8M +$9.47M +17,198 New
Citadel Advisors
8
Citadel Advisors
Florida
$14.2M +$8.51M +15,451 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$12M +$7.21M +13,100 New
Artisan Partners
10
Artisan Partners
Wisconsin
$8.31M +$4.99M +9,057 New
KCM
11
Kennedy Capital Management
Missouri
$4.27M +$2.56M +4,649 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$4.01M +$2.4M +4,367 New
State Street
13
State Street
Massachusetts
$3.91M +$2.34M +4,256 New
Northern Trust
14
Northern Trust
Illinois
$3.64M +$2.19M +3,970 New
AA
15
ALPS Advisors
Colorado
$1.96M +$1.17M +2,131 New
Charles Schwab
16
Charles Schwab
California
$1.77M +$1.06M +1,924 New
Victory Capital Management
17
Victory Capital Management
Texas
$988K +$593K +1,076 New
N
18
Nuveen
North Carolina
$803K +$482K +875 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$760K +$456K +828 New
Norges Bank
20
Norges Bank
Norway
$688K +$413K +750 New
Morgan Stanley
21
Morgan Stanley
New York
$615K +$369K +670 New
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$453K +$272K +493 New
Squarepoint
23
Squarepoint
New York
$340K +$204K +371 New
Millennium Management
24
Millennium Management
New York
$291K +$175K +317 New
UBS Group
25
UBS Group
Switzerland
$283K +$170K +308 New
1
2

APRE Hedge Fund Activity: Q4 2019 in Review

39 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Aprea Therapeutics (APRE) for Q4 2019, worth a combined $591M.

Buyers outnumbered sellers: 39 funds opened new APRE positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $62.5M.

  • 39 institutional investors held Aprea Therapeutics (APRE) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $591M of Aprea Therapeutics stock for Q4 2019.
  • 39 funds opened new Aprea Therapeutics positions in Q4 2019 and 0 closed out, a net change of +39 holders.
  • The largest Aprea Therapeutics buyer in Q4 2019 was Redmile Group, an estimated $62.5M added.

Based on aggregated 13F filings for Q4 2019.